Theme: Advancements in Research Methods to Eradicate Liver Diseases

Liver Diseases 2022

Renowned Speakers

Liver Diseases 2022

We cordially welcome you to attend the 13th International Conference on Liver Diseases & Hepatology which is scheduled during November 14-15, 2022 at Amsterdam, Netherlands.

This year we came up with the refreshing theme Implementing the new research ideas to eradicate Liver Diseases”. The main objective of the conference is to bring together leading academicians, scientists, researchers, graduate students, (GastroenterologistsHepatologistsNephrologistsPathologistsVirologistsOncology) environmental specialist & pharmaceutical specialist and others from all over the world. 

Liver Diseases 2022 is a two days conference organized by Organizing Committee Members where it starts with a keynote session followed by an oral presentation and poster presentations and final ends with the certificate distribution.

Hepatology is the study of Liver, gall bladder, biliary tree and pancreas and its disorders. This is the best chance for all the doctors as well as scientific researchers and students to find out the new techniques in Hepatology and find out the different ways of treatments to be given to the patients affected with Hepatitis. So, don’t miss the opportunity and be a part of it as the new era begins.

With members from around the world focused on learning about Liver Diseases and Hepatology. This is your best opportunity to reach the largest assemblage of participants from the Hepatology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Liver Diseases and Hepatology, treatment and surgery involved are hallmarks of this conference.

Liver Diseases conference 2022 provides a great platform to grow your connections by gathering eminent people like professors, Researchers, scientists, industrialists, Students and delegates to exchange new ideas and knowledge. This conference is mainly focusing on a wide range of topics and allows participants to discuss about the management of liver diseases and Hepatitis. Liver Diseases conference 2022 consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters and video presenters will be judged and awarded during the conference. We encourage a broad participation from all over the world, Conference Series Ltd main motive is to spread the knowledge and exchange the ideas to build a smart and infectious free world.

  • Gastroenterologists
  • Hepatologists
  • Pathologists
  • Gynecologists
  • Radiologists
  • Oncologists
  • Research scholars
  • Doctors and General Physicians
  • Biotechnology and Bioinformatics students
  • Deans and Professors of Medicine & Hepatology departments
  • Professors & Students from cancer research centres
  • R&D department in pharmacy
  • Clinical Development Physicians, Researchers & Scientists
  • Public Health Professional
  • Medical Equipment Manufacturers
  • Hospitals and Health Services
  • Medical & Health care Organizations & Associations
  • Pancreas and Liver research institutes
  • Nurse and nursing education institutions
  • Medical Colleges
  • Business Professionals
  • Distributors/Sales Representatives
  • Pharmaceutical Companies
  • Cancer research universities in Asia-pacific regions

Come put your hand together and join with us @Liver Diseases 2022

Track 1: Liver diseases

Many crucial bodily processes that are necessary are controlled by the liver. It aids in the removal of toxins, energy storage, and food digestion. The lack of those abilities can do a lot of harm to the body if it becomes ill or damaged. Men, women, and kids can all develop one of the more than 100 different types of liver disease. Cirrhosis, alcoholism, hepatitis A, B, C, D, and E, Epstein-Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease, and iron overload are among these conditions (hemochromatosis). The primary signs of a liver imbalance are weakness and weariness, weight loss, nausea, vomiting, and skin discoloration in a yellowish hue (jaundice).

Track 2:  Inherited liver diseases

Genetic transmission of  inherited liver diseases occurs from ancestors to parents and grandchildren. The most severe and persistent inherited liver conditions differ from person to person. Scientists today claim that liver cancer is also a hereditary condition. Hemochromatosis, Wilson's disease, alpha 1-antiprotease, and cystic fibrosis are significant hereditary disorders that can lead to both acute and chronic liver problems. Hemochromatosis, Wilson's disease, a deficiency in alpha 1-antiprotease (antitrypsin), and cystic fibrosis are significant hereditary illnesses that can result in acute and chronic.

Track 3: Liver and Biliary

The body's largest gland, the liver, conducts out a wide range of essential metabolic and excretory processes. The liver is moreover the first place where ingested nutrients and other chemicals entering via the gastrointestinal tract, such as medications and bacterial metabolites, are processed by the body because of its circulatory proximity to the absorptive surface of the gastrointestinal tract. As a result, the liver serves as a gatekeeper that may process beneficial compounds while detoxifying potentially harmful compounds that are ingested, such as hazardous xenobiotics.

Track 4: Liver  Cirrhosis 

Cirrhosis is a late stage of liver scarring (fibrosis) brought on by a variety of liver disorders and conditions, including  chronic alcoholism and hepatitis. Cirrhosis develops because of hepatotoxicity. Your liver strives to heal itself after each injury. Scar tissue is created during the process. Cirrhosis makes it more challenging for the liver to function as more scar tissue develops. Cirrhosis develops because of liver injury. Your liver strives to heal itself after each injury. Scar tissue is generated during the process. Ever more scar tissue develops as cirrhosis progresses, impairing the liver's ability to function. Symptoms of this impairment include ascites (abdominal fluid buildup), hepatic encephalopathy, testicular atrophy in men, and breast enlargement in men. Additionally, cirrhosis might result in spleen enlargement and portal hypertension splenomegaly).

Track 5 : Hepato -Radialogy

Because the liver is a common site for metastatic spread from cancer and because it increases the risk of developing hepatocellular carcinoma, liver imaging is primarily used for accurately diagnosing biliary tract problems. It is also essential for identifying liver injuries or damage and patients with a suspected malignancy.

Track 6 : Liver injury and Immnue Responses

Hepatic irritation is a common sign in a variety of liver diseases, including drug-induced liver poisoning. Kupffer cells, monocytes, neutrophils, and lymphocytes are responsible for the innate safe reaction that results in the provocative phenotype. Additionally impacted by the innate resistive reaction that damages the liver is the adaptable immune system.

Track 7 :  Liver Function

The body's largest internal organ, the liver, is located to the right of the abdomen. It is a major organ that performs a variety of tasks for the body, including the generation of triglycerides, cholesterol, glycogen, and bile, as well as proteins and blood clotting components. The liver detoxifies toxins, filters blood flowing from the digestive system, and breaks down vitamins, proteins, lipids, starches, and medications. Bile that returns to the gut is secreted by the liver.

Track 8: Hepato- Nephrology and Pathology

While kidney histology is normal in HRS, liver pathology is changed. The most typical cause of HRS is liver cirrhosis, which has the appearance of chicken wire on a trichrome stain. The results of laboratory testing on susceptible individuals are used to make the diagnosis of hepatorenal syndrome.

A life-threatening medical illness known as hepato-renal syndrome (HRS) is characterized by a fast decline in kidney function in people with cirrhosis or  fulminant liver failure. Unless a liver transplant is performed, HRS is typically deadly. However, some treatments, such as dialysis, can stop the disease from progressing.

HRS can affect people who have cirrhosis, severe alcoholic hepatitis, or liver failure. It typically happens when liver function declines quickly because of a sudden insult like an infection, gastrointestinal hemorrhage, or excessive use of diuretics

Track 9:Hepatitis and its  types

The liver is inflamed by hepatitis. The disorder could be self-limiting, or it might worsen and lead to cirrhosis, liver cancer, or fibrosis (scarring). The most frequent cause of hepatitis in the world is hepatitis viruses, although it can also be brought on by autoimmune illnesses, other infections, and toxic substances (including alcohol and other medications).

There are five different forms of hepatitis viruses: hepatitis A (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and hepatitis E. (HEV). Due to the weight of illness and death they produce as well as the possibility of outbreaks and epidemic spread, these 5 categories are the most concerning. In hundreds of millions of people, types B and C coupled with cancer are the most common causes of chronic illness and liver cirrhosis.

Track 10 :Hepatities ,Liver Diseases and Pregnancy

The most frequently recognized cause of severe jaundice in pregnancy is intense viral hepatitis. Pregnancy has no impact on how most common infections progress. One of the hallmark symptoms of liver disease is jaundice. The differences in clinical symptoms and side effects across the various viral hepatitis types necessitate serologic testing to determine infection, and the diagnosis is made by a biochemical evaluation of liver function.

Track 11:Hepatitis -Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases.

Track 12:Prevention and Treatment for Hepatitis

Your doctor will first review your medical history to identify any potential risk factors for either infectious or non-infectious hepatitis before diagnosing a patient of hepatitis. The effectiveness of your liver's function can be assessed using blood samples.

A strained, injured, or improperly functioning liver may show high levels of liver enzymes. The organs inside your belly can be visualized via an abdominal ultrasound by using ultrasound waves. It may show the presence of liver tumors, liver dysfunction, or gall bladder abnormalities. Your kind of hepatitis and whether it is acute or   will impact your treatment options.

Track 13: Liver  Transplantation and Surgery

A liver transplant is a procedure in which a donor's partial or whole liver is used to replace the sick heart in a patient. Biliary atresia is an uncommon disorder that affects newborn infants and results in the absence or obstruction of the common bile ducts, which transport bile from the liver and are located between the liver and small intestine. People who are obese are subjected to various forms of  bariatric surgery. The liver can be examined microscopically to get a tissue sample that could be used to identify liver disease. A large needle is used to retrieve a sample of tissue from the liver during a biopsy, which is then analyzed in a lab.

  • Liver Biopsy
  • Bariatric surgery
  • Living donor transplantation
  • Graft rejection
  • Immunosuppressive management            
Track 14: Stem cell treatment on Liver Diseases     
An innovative strategy being investigated in this situation is cell therapy. The primary cells of the liver parenchyma, hepatocytes oversee preserving liver health. They can come from one of three places. Hepatocytes can multiply on their own in a healthy liver to rebuild the functional liver mass, a process that may not be working properly in cirrhosis. Second, there are cells in the liver called hepatic progenitor cells that have the capacity to multiply and develop into hepatocytes.
Cirrhosis, which is caused by fibrous septa dividing the liver parenchyma and impairing both liver function (owing to a decrease in functional mass) and normal intrahepatic venous pressure, is a result of chronic liver disorders (due to increased stiffness). While other causes are still difficult to cure, some can be managed with antiviral therapy for hepatitis B or C virus infection, alcohol abstinence for alcohol-related liver disease, or weight loss techniques for metabolic non-alcoholic fatty liver disease (like genetic disorders or autoimmune problems). Some individuals continue to develop end-stage liver disease and its associated consequences, such as ascites, peritonitis, variceal hemorrhage, or hepatocellular cancer, despite current treatments. The only curative option is still liver transplantation because there is no medication available that targets fibrosis and cirrhosis specifically.
Advanced Cell Therapy
Differentiation of Hepatocytes
Biochemistry in Liver Development 
Transplantation of Cell 
Track 15: Hepatology  and  Nutrition

Pediatric gastroenterologists, hepatologists, dietitians, clinicians, and nurses make up the Gastroenterology, Hepatology, and Nutrition team, which is committed to aid children with simple or serious digestive, liver, and nutritional issues. The Gastroenterology Division's objectives are to provide patients with gastrointestinal and liver disorders with exemplary medical care, to teach gastroenterology, and to conduct cutting-edge biomedical research to advance our understanding of digestive diseases.

Track 16:  Hepatitis Vaccination 

Getting the hepatitis immunizations is the best approach to avoid hepatitis. All people should get vaccinated because it is both safe and effective. Since the hepatitis C virus was discovered more than 20 years ago, research has been conducted to create a vaccine. Compared to the viruses that cause hepatitis A and hepatitis B, the hepatitis C virus is more varied. There are 50 different subtypes of the hepatitis C virus, with at least six genetically unique forms. A universal vaccination would need to offer defense against each of these viral variations.

Track 17:Hepatocellular carcinoma and Transarterial chemo Embolisation

The most well-known kind of adult essential liver growth and the most common cause of death in cirrhotic people is hepatocellular carcinoma (HCC). It occurs when the liver is constantly becoming worse and is most strongly linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins like alcohol or aflatoxin. Alpha 1-antitrypsin deficiency and hemochromatosis are two conditions that increase the risk of treating HCC. Similar to other malignancies, HCC therapy and prognosis depend on the characteristics of the, tumor's histology measurement, extent of growth, and overall health.

Track 18 :Liver Biopsy

A tiny needle is injected into the liver during a liver biopsy to get a tissue sample from the organ. This can be done in a doctor's office, as an outpatient operation, or even during surgery. The tissue is then examined in a lab to assist medical professionals in identifying several liver illnesses and abnormalities. Obtaining a liver biopsy often involves no difficulties. However, internal hemorrhage and bile leaks from the liver or gallbladder might happen seldom.

  • Percutaneous liver biopsy
  • Laparoscopic liver biopsy
  • Transvenous liver biopsy                                                                                                                                                      

Track 19: Clinical trials on Hepatology

Surgical procedure to remove the liver permanently or temporarily is referred as a liver resection. It is also known as a full or partial hepatectomy. When a diseased liver is removed from a deceased donor after a transplant, the procedure is known as a complete liver resection (cadaver). Additionally, a portion of liver tissue obtained by a partial hepatectomy can be given by a living donor. Either a conventional open procedure or a minimally invasive technique can also be used to carry out the surgery.


Recent Research on Liver Diseases in Singapore:

Hepatocellular carcinoma, the most prevalent type of  liver cancer, has been divided into three distinct subgroups by a research team from Singapore University using integrated data analysis. This categorization should aid for focused treatment.

Singapore– Being the second-most prevalent cause of cancer-related death worldwide, liver cancer continues to be a significant issue in healthcare across the globe. Previous research revealed that this illness demonstrates significant heterogeneity, particularly in its most common type, hepatocellular carcinoma (HCC). However, the inability to combine data from diverse sources into a single categorization system has hindered efforts to classify HCC more precisely.

By combining information on mutations, gene expression patterns, and immunological condition, a research team from Tokyo Medical and Dental University (TMDU) has achieved significant progress in this area by illuminating the differences across HCC cases. The study, which was just published in the journal Biomedicine, demonstrates that there are three different varieties of this illness, which should aid in forecasting each patient's prognosis and upgrading overall care.

Global Hepatology and Liver Diseases market (2018-2025)

The market for infectious diseases and treatments for the liver is anticipated to grow from US$ 2,011.2 million in 2017 to US$ 4,056.4 million in 2025. From 2018 to 2025, the market is anticipated to expand at a CAGR of 8.1 percent.

The increase in the number of medications introduced to the market is primarily responsible for the expansion of the liver cancer therapy market. Thus, it is anticipated that the market for treating liver diseases, particularly liver cancer, will rise due to the introduction of new medications. For instance, the FDA authorized Merrimack Pharmaceuticals, Inc.'s Onivyde medication in October 2015 as a component of a therapy plan for advanced cancer.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View